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A four step synthetic sequence leading to the title
compounds through the formation of 4'-methylbiphenyl-
2-carboxylic acid via catalysed "Gomberg reaction" is
described.
The role of renin-angiotensin system (RAS) to
regulate blood pressure and various other
cardiovascular functions is well documented'. The
use of angiotensin II receptor antagonists is
perhaps the best possible tool to modulate RAS.
Numerous AT! selective nonpeptide antagonists
have been synthesised in the past several years",
Recently efforts have been made to design and
synthesise angiotensin II receptor antagonists
which can block both AT! and AT2 receptors':".
Such compounds known as 'balanced antagonists'
are considered to produce less adverse effects on
long term administration. A great number of
compounds structurally related to DuP 7535-8 and
its carboxy derivative EXP 77112,8 have been
synthesised by several laboratories/:'".
The present note reports a newer synthesis of 2-
substituted benzimidazole analogues of EXP 7711,
because benzimidazoles are reported to have
modest binding affinity for both AT! and AT2
receptors':" .
A four step synthetic sequence for the
preparation of the title compounds is depicted in
Scheme I. The structure of various compounds
reported here is confirmed from IR and PMR
spectral analysis.
2-Substituted benzimidazoles la-c were
prepared from a-phenylenediamine and various
carboxylic acids under reflux followed by the
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142°C (lit. m.p. 140°C)2 was prepared by using the
Gomberg reaction'v'" between the aqueous
solution of diazotized anthtanilic acid and toluene.
Gomberg reaction being slow and poor yielding
was later accelerated by the addition of acetonitrile
802 INDIAN J CHEM, SEC.B, AUGUST 1998
as co-solvent, which not only catalysed the reaction
but also gave improved yields".
4' -Methylbiphenyl-2-carboxylic acid 2 IS
converted into 4' -(bromomethyl) biphenyl-2-
carboxylic acid 3 via benzylic bromination with
NBS in CCl4 in the presence of catalytic amount of
benzoyl peroxide under reflux. The final step
involving the coupling of 2-substituted ben-
zimidazoles'<" la-c with 4' -(bromomethyl)-
biphenyl-2-carboxylic acid 3 was carried out using
K2C03 in DMF.
After the success of trial coupling between lb
and the readily available benzyl chloride giving the
expected 1,2-dibenzylbenzimidazole 4, we then
carried out the coupling of la-c with 4'-
(bromomethyl)biphenyl-2-carboxylic acid 3




Melting points were taken in a cone. sulphuric
acid bath and are uncorrected (Table-I). IR spectra
were recorded in KBr on FTIR-8101, Shimadzu
Spectrophotometer (vmax in cm') and PMR spectra
on AC300F, 300, MHz and BZH 200/)2, 200MHz
Bruker spectrometers in CDCh (chemical shifts in
8, ppm).
General procedure for the preparation of 2-
substituted benzimidazoles la-c. An equimolar
mixture of o-phenylenediamine and respective
carboxylic acid in 4N-HCI were heated under
reflux for 2-4 hr. The contents were cooled to room
temperature and rendered distinctly alkaline by the
gradual addition of cone. ammonia solution. The
precipitated solid was filtered, washed with ice
cold water and recrystallised from aq. ethanol with
the addition of decolourizing carbon.
2-Phenylbenzimidazole la. 'PMR (CDCh): 8
8.013 (m, 4H), 7.001(m, 5H), 4.661 (br. s, IH).
2-Benzylbenzimidazole lb. PMR (CDCh): 8
7.283 (m, 9H), 4.470 (br.s, IH), 4.195 (s, 2H,
CH2).
2-Styrylbenzimidazole lc. IR (KBr): 3400 (NH
stretching), 1625 (Aryl conjugated C=C
stretching); PMR (CDCh): 8 7.521 (m, 5H), 7358
(m, 4H), 7.64, 6.44 (2 doublets, IH each, CH=CH,
J=16Hz), 4.858 (br.s, IH).





































4' -Methylbiphenyl-2-carboxylic acid 2. This
preparation was carried out using anthranillic acid
and involved following two steps:
(a) Diazotization of anthranilic acid.
Anthranilic acid (0.01 mole) was added with
stirring to 100mL of water containing 14mL of
cone. H2S04 and the contents were cooled to 5°C.
Diazotized by the gradual addition of (0.101 mole)
of sodium nitrite in 20mL of water with continuous
stirring to an end point with starch iodide paper.
(b) Gomberg reaction of the diazotized
anthranilic acid with toluene. The above
diazotized solution was filtered and transferred to a
2L conical flask surrounded by ice water. 400mL
of toluene and 40mL of acetonitrile as co-solvent
were added to this. The contents were stirred
vigorously and to the stirred solution was added an
ice cold aq. solution of 80g of sodium acetate
trihydrate in 200mL of water in instalments while
maintaining the temperature 5-lOoC. The stirring
continued for 24 hr, after first 3 hr the reaction was
allowed to proceed at room temperature. The
organic layer was separated, washed with water,
dried over anhyd. Na2S04 and excess toluene was
removed in vacuo. The residue was allowed to cool
and treated with dil HCI and more water was added
and extracted with ether. The ether extract was
washed with water, dried over anhyd. Na2S04 and
was concentrated to furnish 40% of 2 as colourless
solid m.p. 142°C. IR (KBr): 1700 (C=O stretching
of carboxylic acid), 3360-2500 (broad band bonded
OH stretching of carboxylic acid), 830 (2 adjacent
H), 750 (4 adjacent H); PMR (CDCh): 8 7.94 and
7.93 (two overlapping doublets, IH each, J=8Hz),
7.530 (t, 2H, J=8Hz), 6.968 (m, 4H), 2.375 (s, 3H,
CH3), 10.421 (br. s, IH, COOH exchangeable).
Preparation of 4' -(bromomethyl)biphenyl-2-
carboxylic acid 3. A solution of 2 (0.01 mole), N-
NOTES 803
bromosuccinimide (0.01 mole) and dibenzoyl
peroxide (0.0002 mole) in 150mL of CC14 was:
refluxed for' 3 hr. After cooling to room
temperature, succinimide was removed by filtration
and the filtrate was washed with water, brine and
finally with distilled water and dried over anhyd.
Na2S04. This upon evaporation afforded 80% of 3
as an yellowish white oil which upon cooling
changes to a semi-solid mass. The crude product
was used without further purification. PMR
(CDCh): 0 8.127 (d, 2H), 7.935 (m, IH), 7.914 (m,
IH), 7.542 (m, 2H), 6.949 (m, 2H), 3.040 (s, 2H,
CH2-Br), 10.421 (br. s, IH, COOH exchangeable).
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